Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study
NCT03456648Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in Atrial fibrillation (AFib), sponsored by UZ Leuven. Started Sep 2016; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03456648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03456648.